AIM
GSK icon

Acrospire Investment Management’s GSK GSK Stock Holding History

Acrospire Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,760
Closed -$95K – 608
2017
Q2 		$95K Buy
1,760
+1,200
+214% +$64K 0.09% 281
2017
Q1 		$30K Sell
560
-240
-30% -$12.2K 0.02% 1351
2016
Q4 		$39K Sell
800
-240
-23% -$11.9K 0.02% 1520
2016
Q3 		$56K Buy
1,040
+480
+86% +$26.3K 0.04% 980
2016
Q2 		$30K Hold
560
– – 0.02% 1386
2016
Q1 		$28K Buy
+560
New +$27.9K 0.02% 1354

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Acrospire Investment Management's GSK Position: Q3 2017 in Review

Acrospire Investment Management sold out of GSK (GSK) in Q3 2017, closing a stake of 1,760 shares — an estimated $95K sold.

Acrospire Investment Management first reported a position in GSK in Q1 2016 and held it in 6 quarters. The position peaked at $95K in Q2 2017. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Acrospire Investment Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,760 GSK shares in Q3 2017, an estimated $95K.
  • Acrospire Investment Management first reported a position in GSK in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's GSK position peaked at $95K in Q2 2017.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.